According to a report published in eLife, a new antimalarial medicine is being released at a dose that is too low to be effective for all people who require it.
A ground-breaking discovery by a multinational team led by Penn State researchers has given new hope against malaria, which kills over 500,000 people each year, disproportionately impacting children under the age of five, pregnant women, and HIV patients.